Eric dEsparbes

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Clarke Neumann, Attorney-in-Fact for Eric d'Esparbes
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric dEsparbes:

Company Role Class Num Shares Value Price $ Report Date Ownership
BIORA THERAPEUTICS, INC. Chief Financial Officer Common Stock 575,832 $385,807 $0.6700 15 Aug 2024 Direct

Insider Reports Filed by Eric dEsparbes

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BIORQ BIORA THERAPEUTICS, INC. 15 Aug 2024 1 -$18,646 4 Chief Financial Officer 16 Aug 2024, 16:05
BIORQ BIORA THERAPEUTICS, INC. 15 Feb 2024 1 $0 4 Chief Financial Officer 15 Feb 2024, 16:05
BIORQ BIORA THERAPEUTICS, INC. 15 Aug 2023 2 -$125,669 4 Chief Financial Officer 17 Aug 2023, 17:22
BIORQ BIORA THERAPEUTICS, INC. 15 May 2023 1 -$9,403 4 Chief Financial Officer 17 May 2023, 16:56
BIORQ BIORA THERAPEUTICS, INC. 15 Mar 2023 3 -$28,713 4 Chief Financial Officer 17 Mar 2023, 21:16
BIORQ BIORA THERAPEUTICS, INC. 15 Feb 2023 1 -$931 4 Chief Financial Officer 17 Feb 2023, 15:15
BIORQ BIORA THERAPEUTICS, INC. 03 Jan 2023 1 $0 4 Chief Financial Officer 05 Jan 2023, 15:05
BIORQ BIORA THERAPEUTICS, INC. 15 Nov 2022 1 -$1,402 4 Chief Financial Officer 16 Nov 2022, 20:48
BIORQ BIORA THERAPEUTICS, INC. 15 Aug 2022 1 -$6,190 4 Chief Financial Officer 16 Aug 2022, 17:58
BIORQ BIORA THERAPEUTICS, INC. 15 May 2022 3 -$7,790 4 Chief Financial Officer 17 May 2022, 17:18
BIORQ PROGENITY, INC. 15 Apr 2022 2 $0 4 Chief Financial Officer 19 Apr 2022, 16:23
BIORQ PROGENITY, INC. 15 Feb 2022 1 -$9,346 4 Chief Financial Officer 17 Feb 2022, 15:05
BIORQ PROGENITY, INC. 15 Aug 2021 1 -$9,492 4 Chief Financial Officer 17 Aug 2021, 16:00